,

Size: px
Start display at page:

Download ","

Transcription

1

2 ,

3

4

5

6 CT MRI

7

8

9

10

11

12

13

14

15 p

16 p - p - p - p - p - p - p - p - p p - p - p - A B

17

18

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (

More information

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1, 1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

More information

肝臓病教室201207v2配布用.pptx

肝臓病教室201207v2配布用.pptx 24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0

More information

8 8 0

8 8 0 ,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7

More information

1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%

More information

A 01 2 015 10 11 12 G 011 2 0111 67

A 01 2 015 10 11 12 G 011 2 0111 67 66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012

More information

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008

More information

Digital Photo Professional Ver1.6(Windows)

Digital Photo Professional Ver1.6(Windows) Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2

More information

がん診療におけるFDG FDG-PET/CTの役割

がん診療におけるFDG FDG-PET/CTの役割 PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

More information

2

2 1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem

More information

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1 10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C

More information

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1-

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD

More information

NEDO

NEDO 10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006

More information

天草郡市医師会第139回(臨時)代議員会

天草郡市医師会第139回(臨時)代議員会 A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (

More information

-2-

-2- Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-

More information

untitled

untitled 19 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15 19 19 1 17,676 20.0 2 20,970 24.1 3 4,967 23.2 104,10919 4 8,234 18.0 11,428 22.4 1 0 10,954244 17,107 18.7 136 4.8 12,653205 1,239 13.2 10,056686 27,305514

More information

- 1 -

- 1 - 19 21 - 1 - - 2 - - 3 - - 4 - 19 21 21 2224-5 - 19 2007 21 2009 H18 H27 18 27 10 H18 H22 18 22 22 H19 H21 19 21 21-6 - 20 21 19 2,449,254 2,495,506 1.9% 2,603,427 4.3% 1,593,428 1,582,704 0.7% 1,552,160

More information

橡アロマセラピー症状別処方例.PDF

橡アロマセラピー症状別処方例.PDF 1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 20 20 2003 15 1990 1990 2002 2002 12 12.....?. or 32 TN M0 1999 10 T1N0M0 93 10 dental CT dental CT MRI MRI : 55 TN0M0 1993 12 57 T3N0M0 938 1990 T1N0M0 1989 12 1990 99 99 4 T4 T4 T4 v.s.t2,3 T4 v.s.t2,3?

More information

untitled

untitled 5 10% 1 13 15cm 3 4cm 2 RS P Rb Ra S RS Ra Rb P 4 S RS CT MRI Stage 0 Stage I Stage I Stage II Ra Rb P TEM TEM ISR TEM Transanal endoscopic microsurgery 5cm 4cm 5cm TEM 1 2 3 10cm RS 6cm Ra 4cm Rb 2cm

More information

「東日本大震災に係る対応―保険診療・地域医療再生基金・災害復旧費補助金・医療法等について(第1報)」について

「東日本大震災に係る対応―保険診療・地域医療再生基金・災害復旧費補助金・医療法等について(第1報)」について 2012 3 28 2011 3 1 1 2012 3 2012 3 28 2012 3 28 2012 3 28 2012 3 28 1. 1 3 11 1 2 3 15 17 3 4 5 1 2012 3 28 5 10 6 3 18 7 5 8 3 23 9 2 2012 3 28 2011 3 23 23 10 3 2012 3 28 4 2012 3 28 5 2012 3 28 3 24

More information

00 p01-24

00 p01-24 Feb-Mar Special 3 2 1 P.4 2 P.11 3 P.16 1 100m 100 400m JOC 100 4 Sportsmedicine 2011 NO.128 Sportsmedicine 2011 NO.128 5 10 P.11 1980 70 MRI MRI 1 2 6 30 11 3040 50 10 10 71 67 25 Sportsmedicine 2011

More information

C79 A11 A12 A13 A19 B11 B12 B13 B14 B15 B19 B21 B22 B23 B24 B25 C11 C12 C19 C21 C31 C32 C33 C34 C35 C36 C37 C39 C41 C51 C52 C53 C54 C55 C61 ( ) C62 C6

C79 A11 A12 A13 A19 B11 B12 B13 B14 B15 B19 B21 B22 B23 B24 B25 C11 C12 C19 C21 C31 C32 C33 C34 C35 C36 C37 C39 C41 C51 C52 C53 C54 C55 C61 ( ) C62 C6 C79 A11 A12 A13 A19 B11 B12 B13 B14 B15 B19 B21 B22 B23 B24 B25 C11 C12 C19 C21 C31 C32 C33 C34 C35 C36 C37 C39 C41 C51 C52 C53 C54 C55 C61 ( ) C62 C63 C64 C71 C72 C73 C74 C99-1 - A11 A12 1 1 A13 A19 11

More information

10mm -1-

10mm -1- PKD.45.6.45.3.46.8.45.6.55.9.54.3.56.4 H.3.3 4 H.7.3 15.62.6 10mm -1- -2- CT CT CT 90 CT MRA MRA MR MRI CT -3- Hunt & Kosnik 1974 Grade Grade Grade a Grade Grade Grade Grade 2922 78.7 % 8.6 % 4.4 % 8.3

More information

<836C83628367834A8374834692B2B895F18145706466>

<836C83628367834A8374834692B2B895F18145706466> 1. 30 5 500 2 7 100 2 10 100 2007 4 1 7,200 6,800 7 NPO 1,200 1 12 15 2 1.5 0.5 30 2 24 5 27 16.8 28 2.3 10,500 / 3 3,800 117 2 3 6 6,000 1 1 1 2 2006 1 6, 000 + + 8 30 17 00 7.5 13 2 B2 2. 50 2 3 1 1

More information

鼻副鼻腔疾患に伴う頭痛,顔面痛

鼻副鼻腔疾患に伴う頭痛,顔面痛 118 833 : VV CT : Sluder CT CT VV V V V 118 834 2015 1 V V V V Sluder neuralgia Sluder Sluder Sluder neuralgia V C2 4 CT MRI CT CT CT OM V V V V 118 835 a b c d e f g h 1 CT : : : : : : 118 836 2015 a

More information

Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc

Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc DPC SPECT 2 2013 9 DPC/PDPSDiagnosis Procedure Combination / Per-Diem Payment System 1 DPC DRG/PPS: Diagnosis Related Groups / Prospective Payment System 2003 2008 7 2008 DPC 2012 1,500 DPC SPECT 70% DPC

More information

被曝二世健康影響調査

被曝二世健康影響調査 19 3 1 1. 3 2. 4 4 4 6 7 8 8 3. 10 10 10 11 12 4. 14 14 15 15 15 15 16 17 17 18 18 19 19 5. 20 6. 21 22 2000 7 5 4 6 4 77,000 5mGy 5mGy 24,673 57.3 84.5% 11,951 BMI 1 - 1Gy 0.91 1Gy 0.98-48.6 48.4 19 10

More information

医療レーザー脱毛の威力と限界

医療レーザー脱毛の威力と限界 .... mm. CT WH W H W H W H... kcalkcal. 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D. kg mm . CT WH W H W H W H... kcalkcal . 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D.

More information

特許権侵害に対する損害賠償額の算定に関する裁判例の動向

特許権侵害に対する損害賠償額の算定に関する裁判例の動向 [*361] 1998 1999 102 1 105 3 102 3 102 1 102 2 102 3 1. 2. 102 1 2.1 2.2 2.3 2.4 3. 102 2 3.1 3.2 4. 102 3 5. 1. 1) 102 1990 3 1 102 1 10 102 2 102 2 10 102 3 [*362] 2) 1998 1999 102 1 105 3 102 3 2 3)

More information

http://www.city.saitama.jp/www/contents/1161852587708/index.html 10 ( ) ( ) (1) (2) (1) (2) (3) (4) (5) 6 1 2 2 3 2 3 2 3 http://www.city.saitama.jp/005/001/017/006/003/p033839.html

More information

「学生とシニア」の対話実施報告書

「学生とシニア」の対話実施報告書 in 2009.11.30 1. 2005 6 38 3 2 2. 3 3. 1 21 11 7 9301630 11 6 18302030 2 1 1 3 4 (90 )(50 )(75 ) 4. 5.(70 ) 6. 5 2 G1 (CO2 ) G2 () G3 () G4 (-) G5 () 5 2 10 1 CO2 Q&A 1 7. 3 2 3 9%, 62%, 27%, 2% 71% 23%,

More information

評価結果報告書の概要版(平成20年度)

評価結果報告書の概要版(平成20年度) 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76

More information

21 1 503604705 MRI CT 1 3 MRIMRS 5 5 5 5 5 6 7 8 17 1 17 2 17 3 17 4 18 5 19 21 1 23 2 1 27 3 2 48 4 3 88 5 105 6 110 7 118 MRS MRS ATP 312CT 65 60 1 2 1 1 1 2 1 2 2 X CT MRS 3 36657269 MRIMRS 1.5TMRSymphony

More information

TM Reverse Shoulder手術手技書

TM Reverse Shoulder手術手技書 Zimmer Biomet Trabecular Metal Reverse Shoulder System Surgical Technique 1 Trabecular Metal Reverse Shoulder 22500BZX00475000 Vivacit-E 22700BZX00233000 2 Trabecular Metal Reverse Shoulder TM / / 3 3

More information

NHS G.P. CT MRI OECD

NHS G.P. CT MRI OECD NHS G.P. CT MRI OECD WHO WHO CM ,, bio-medical bio-psycho-social bio-psycho-socio-ethicalecological existential WHO physical mental social well-being spiritual spiritual mental heath spiritual health

More information

JPN-1

JPN-1 EF70-200mm f/2.8l IS II USM JPN JPN-1 a JPN-2 JPN-3 1. JPN-4 2. 3. JPN-5 4. JPN-6 5. JPN-7 6. JPN-8 7. JPN-9 JPN-10 8. 9. JPN-11 10. JPN-12 11. 12. 13. JPN-13 14. JPN-14 JPN-15 canon.jp/ef 050-555-90001

More information

MP-E 65mm f/2.8 1-5× 使用説明書

MP-E 65mm f/2.8 1-5× 使用説明書 MACRO PHOTO LENS MP-E 65mm f/2.8 1-5 JPN JPN-1 a JPN-2 JPN-3 1. 2. JPN-4 JPN-5 JPN-6 3. JPN-7 JPN-8 4. JPN-9 5. JPN-10 6. 7. JPN-11 8. JPN-12 canon.jp/ef 050-555-90001 JPN-13 CT1-7525-010 CANON INC. 2002

More information

science

science science IT PERSON TO PERSON EU IT IT WHO TV I T Harvard University Brigham and Women s Hospital, Renal Division UCSF CT MRI IT 1 40 17 3 27 Winslow 1949 Impact Factor 50 1 16 1 NIH Samuel W. Cushman

More information

S22 vol. 38 Suppl. 2013 38-3-2 38-3-3 38-3-4 38-3-5 JA 4 6 15 14:35 15:15 3 38-4-1 1 JA 38-4-2 10 38-4-3 38-4-4 5 5 6 15 15:20 16:10 3 38-5-1 1 38-5-2

S22 vol. 38 Suppl. 2013 38-3-2 38-3-3 38-3-4 38-3-5 JA 4 6 15 14:35 15:15 3 38-4-1 1 JA 38-4-2 10 38-4-3 38-4-4 5 5 6 15 15:20 16:10 3 38-5-1 1 38-5-2 vol. 38 Suppl. 2013 S21 1 6 15 11:25 12:15 4 38-1-1 38-1-2 US 38-1-3 1 38-1-4 38-1-5 2 6 15 13:40 14:30 3 38-2-1 1 38-2-2 38-2-3 CHI-Q 38-2-4 1 38-2-5 IgG4 3 6 15 13:40 14:30 4 38-3-1 S22 vol. 38 Suppl.

More information

2015 3 1.... 1 2.... 2 (1)... 2... 2... 3... 4 (2)... 5... 5... 6 (3)... 7 DPC... 7... 8 3.... 11 (1)... 11... 11... 12... 14 (2)... 15... 15... 16 (3)... 17... 17... 17 4.... 19 (1)... 19 (2) SWOT...

More information

17高度化-8 中山間地域活性化のための機械化・情報化推進可能性調査報告書

17高度化-8 中山間地域活性化のための機械化・情報化推進可能性調査報告書 14 24 34 44 2000 9 1974 1980 1985 1987 1989 1990 1993 10 1990 1993 2000 2.2-1 2 7001,000 ppm LPG pec MRI 3030 30 ECpH PHS 100m 7 15 70cm JFE 28 1 4,800 1 8000 2000 2001 60 3030

More information

() CT X X Ver.5 64 ( 3.0 % / 24,, 25 H23 1 Dr 24 24 2 1 25 RI RI ICU 24 25 B 4500 13000 AHA-PALS 5 PALS 24 25 24 25 24 ICU 24 25 24 1 VA VA 25 25 VA HD VA 20 150 () () 25 2 24 25 24 24 414 102 25

More information

★プログラム並べかえ.indb

★プログラム並べかえ.indb 1 2 3 1 S180 S181 S182 S183 2 3 S184 S185 MRI S187 S188 S189 1 2 1 2 S 37 B flow imaging 1 1 1 2 1 1 S190 2 IVUS 1 2 3 4 5 1 2 S191 3 4 5 : MDCT MRI DSA S192 1 1 1 2 1 2 MR MRI FUS HIFU S194 S195 S196

More information

北辰同窓会36号-02.21修正

北辰同窓会36号-02.21修正 36 FEB, 2011 20112 36 1 GDPOECD 1.5 0.1910 1 2 4 29 Web 40 3,500 22 9 1 22 4 3,279 6 6 6 6 22 7 28 208 1971 9 1976 3 1976 4 1977 11 1983 7 1989 5 Russell Ross 1990 5 1994 7 2002 4 2004 8 1122 9 125 8 313

More information

2007 116 20 1 19 2 6 2 19 2 2007 4 2

2007 116 20 1 19 2 6 2 19 2 2007 4 2 http://www.shijuku.net 2007 116 20 1 19 2 6 2 19 2 2007 4 2 1/14 New Years Party 2007 In NEW YEAR PARTY 330 Wii 4 Wii ii 1/14 NEW YEAR PARTY 11 277-0852 1-6-5 04-7141-5101 04-7141-5106 www.sougakusya.com

More information

本文01id5.indd

本文01id5.indd 1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906

More information

untitled

untitled 436 2112 12 436 2112 12 200912 12 800 900 1000 1100 1200 1300 1400 830 5F 900949 9491031 11051140 11401201 12061300 857900 10311050 10501105 13051340 13401422 5F 830 10301700 4F 403 11001150 5F 11551245

More information

健康解体新書医人医国

健康解体新書医人医国 Preseted by Tanaka Medical Group 健康大百科, ページ 1 5 6 6 7 7 11 11 13 16 19 22 25 27 Preseted by Tanaka Medical Group, 1 30 34 37 40 43 46 50 53 58 61 65 69 75 78 83 87 92 94 98 101 106 Preseted by Tanaka Medical

More information

平成15年度先進的情報技術活用モデルシステムの開発

平成15年度先進的情報技術活用モデルシステムの開発 2 3 IT SI (1) (2) (3) (4) 24 (1)(4) 61 FM CATV IT 500 320 8,000 16 12 4 1 5 CT NTT ADSL ()( MIL )(DICOM ) () MIL (Web) / Web 2 6 (Web)CT 3 7 ( ) 24 4 8 DICOM CT () 9 5 CMC() () () ()NTT-ME 10 ( ) () CT

More information

32 TEL: 0959-52-3000 FAX: 0959-52-4467 Email: nkh@orange.ocn.ne.jp URL: http://www.kamigoto-hospital.jp/ 1 73 MRI IT IVR PTCA 74 MC CT) NECMega-Ork 75 Web HTLV-IATL 2 ICU Holter MD-C T MRIX DSAFCR 3 4

More information

untitled

untitled 11 10 267 6 129 48.3 6 63 2 1 2JIS ME JIS T 1005JIS 1994 1 11 A 10 1999 5 3 13 ME 4 2 11 B B 1999 4 10 267 6 B 7 9 6 10 12 3 11 Excel MODE Excel STANDARDIZE STANDARDIZE(X,)X AVERAGE STDEVP Excel VAR 0.5

More information

ml ml ~ml : ml

ml ml ~ml : ml ml ml ~ml : ml , ) RI CT MRI( MRI (T2T1 MRI MR Mokri Mokri Mokri ICHD-II) Schievink post-lumbar puncture headache) 1938 Schaltenbrand spontaneous aliquorrhea( 1958 Shenkinlow cerebral spinal fluid pressure

More information

e-seeds jp A A Kumamoto University Teaching Online MEMedical Engineering e 17 - - Medical Engineering e Web - WG -- - S A B Web e-seeds jp e-seeds jp SAB e - - - - H H ISO ISO FD

More information

本文/一般演題_吉田

本文/一般演題_吉田 184 quality of lifeqol mmhg Hb gdl CA Uml Niveau Hb Hb gdl RCC CT MRI T 185 CT A B MRI A:T B:T Douglas red spot S ml RCC 186 A B mg CAUml S MRI A B 187 188 S mg Sampson JA. Intestinal adenomas of endometriosis

More information

(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3)

(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3) ...1...3...3 (1)...3 (2)...5 (3)...6 (4)...7...9 (1)...9 (2)...10 (3)...13 (4) 14 (5)...15...16 (1)...16 (2)...19...21 (1)...21 (2)...22 (3)...24...26...26 (1)...26 (2)...28 (3)...30 (4)...31 (5)...35

More information

AD 2004/8/22 1. 30 90 mmhg 2. 3 100 refilling COPD etc. etc. PCPS IVR Helical CT DSA IVR DVT US/CT Scintigaraphy Ventilation / Perfusion VP scans High probability R DSA Gold standard MSCT

More information

CTとMRI (Page 1)

CTとMRI (Page 1) 目 次 CT と MRI 1 CT 3~5 5 6.7 7 MRI 8 8.9 9.10 10.11 2 Contents C T と M R I についての疑問に答えます 2 目次 1 CT 1.CT とは Q CT ってどんなもの? A(コンピューター断層撮影)の略です C 1.CT とは 3 4 1.CT とは 2. 適応となる疾患 Q 適応となる循環器疾患は? A当 C T 院でで撮使影用でしきてるい心る血

More information

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - 20log10 150 = 44 20log10 150 = 44-7 - - 8 - - 9 - - 10 - L ks X n + X 2 2 ) ( 1) ( 1 = X X n S n n n X L k k n X n X S n L n k - 11 - - 12 - - 13 - - 14 - - 15 - - 16

More information

Adobe Rader 9 16 17 17 18 19 20 14 22 23 23 24 25 26 35 37 39-2 - Copyright (C) 2007 jiko-zero.info All rights reserved

Adobe Rader 9 16 17 17 18 19 20 14 22 23 23 24 25 26 35 37 39-2 - Copyright (C) 2007 jiko-zero.info All rights reserved - 1 - Copyright (C) 2007 jiko-zero.info All rights reserved Adobe Rader 9 16 17 17 18 19 20 14 22 23 23 24 25 26 35 37 39-2 - Copyright (C) 2007 jiko-zero.info All rights reserved (e-book)14 850-3 - Copyright

More information

4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2

4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5

More information

01-3 目次 .xls

01-3 目次 .xls 119 6 (170 ) 5 4 3 2 1 F F WC -1-2 -1-2 C C A P D 612 (1B) 613 (1B) 615 (1B) 616 (1B) 617 4B 611 B 610 B 608 B 607 B 606 B 605 B 603 B 602 B 601 (1B) 512 (1B) 513 (1B) 515 (1B) 516 (1B) 517 4B 518 (1B)

More information

診療所ごとの診療状況 一方 診療所では 外来診療を実施 と回答した診療所は 73 か所 (36.3%) 入院診療を実施 と回答した病院は 2 か所 (1.0%) となっており いずれも実施していない との回答が 124 か所 (61.7%) であった 診療所のてんかん診療実施状況 ( 有効回答数 =

診療所ごとの診療状況 一方 診療所では 外来診療を実施 と回答した診療所は 73 か所 (36.3%) 入院診療を実施 と回答した病院は 2 か所 (1.0%) となっており いずれも実施していない との回答が 124 か所 (61.7%) であった 診療所のてんかん診療実施状況 ( 有効回答数 = 3. 調査結果 (1) てんかん診療の状況 問 1 てんかん診療を行っている医療機関 診療科の状況 病院ごとの診療状況 てんかんの 外来診療を実施 と回答した病院は 32 か所 (74.4%) 入院診療を実施 と回答した病院は 30 か所 (69.8%) となっており いずれも実施していない と回答した病院は 8 か所 (18.6%) であった 病院のてんかん診療実施状況 ( 有効回答数 =43)

More information

untitled

untitled ????? 1 AED mg/dl 2 MESS 3 Effect of amiloride on endoplasmic reticulum stress response in the injured spinal cord of rats European Journal of Neuroscience, Vol.,pp. -, 4 ? ;?! DVD?!! 5 6 ; 7 FAX TEL/FAX

More information

CT_08-01.ai

CT_08-01.ai 2009-12 CT55DD 80,000 CTF55B 8,000 CTF55D 3,200 41m 2 BIO HEPA ECO 5 21 20m 2 1210 4.3 1,542 http://www.kuusei.jp/ https://ssl.mhiair.co.jp/app/ contact/?form_number=3 https://ssl.mhiair.co.jp/shop/

More information

原発緊急講演

原発緊急講演 2011 3 11 2 46 9.0 2011 2 22 11,000 1995 1 17 7.3 350 1923 9 1 45 tsunami 1 6 1 3 4 6 1 3 1,3 2 1 Bq 1 PBq 1000 85 10.7 22PBq 90 28.8 190PBq 95 64 5900PBq 106 372 700PBq 131 8 3100PBq 133 5.24 6300PBq

More information

Microsoft Word - 平成24年度医学部卒業試験問題-2.docx

Microsoft Word - 平成24年度医学部卒業試験問題-2.docx 24 2012.10.25 13:00 15 00 5 2 10 20 60 80 110 10 1 6 7 /kg 1 12 20 30:2 AED 3 1 2 119 2 2 2 X X SpO 90% 60mmHg Primary Survey FAST CT 90% 100mmHg FAST 1 2L FAST(Focused assessment with sonography for trauma)

More information

第1回日本産婦人科

第1回日本産婦人科 e e TEL045-231-0960 TEL03-3433-1111 3360 4 2 1 1024768 OS RGB -15pins Dsub-15pins PowerPoint PC WindowsXPMicrosoft PowerPoint2002 Microsoft Power Point ( PC ) Windows USB CD-R PC 30 PC PC 36

More information

「若年不安定就労・不安定住居者聞取り調査」報告書

「若年不安定就労・不安定住居者聞取り調査」報告書 2008 3 2006 2007 3 19 6 7 5,400 2007 4 5 19 94 1 2 2007 5 i 2007 6 12 100 100 1 2 2008 3 ii 1960 1990 iii = 1990 = = iv 5 5 v & = 2 24 = 1990 10 vi vii i iii 1 3 1.1.............................................

More information

... 3 CT

... 3 CT CT915 ... 3 CT915... 4... 5... 6... 7... 11... 14... 16... 18... 19... 22... 24... 25... 26... 28... 29... 30... 31 2 3 CT915 120 120 1 1 31 31 4 CT915 s t CR2032 5 1. 2. 5 3. 6 CR2032 CR2032 1. / 1 2.

More information

数学演習:微分方程式

数学演習:微分方程式 ( ) 1 / 21 1 2 3 4 ( ) 2 / 21 x(t)? ẋ + 5x = 0 ( ) 3 / 21 x(t)? ẋ + 5x = 0 x(t) = t 2? ẋ = 2t, ẋ + 5x = 2t + 5t 2 0 ( ) 3 / 21 x(t)? ẋ + 5x = 0 x(t) = t 2? ẋ = 2t, ẋ + 5x = 2t + 5t 2 0 x(t) = sin 5t? ẋ

More information

1

1 1 6 7 8 9 10 11 12 13 14 15 21:00 22:00 23:00 24:00 18:00 19:00 20:00 16 1 3 ). ). ). 6 ). ). 9 10 12 ). ). 15 ). ). ). 20 ). ). ). 26 2 ). 2 39 3 ). 1. 2. 3. 4. 4 5. 6. ). 5 ). ( ) ( TWITraining

More information

untitled

untitled 1 N=14,685 2 3 4 5 6 CT 7 8 9 10 11 540 3female athlete triad) growth spurt,growth rush Cm/ 15 10 5 7 10 15 12 13 Oslo Sports Trauma Center 1992 Bahr,R.Br.J.SportsMed. 2005 ACL ACL ACL ACL a: b: 5 14 15

More information

PJ NPO 3 28 NPO3

PJ NPO 3 28 NPO3 NPO 4 2 12 10 PJ NPO 3 28 NPO3 21 32 31 21 1950 9.3 19.7 6.5 75.3 42.8 8.9 5.8 9.2 25.4 8000 3 6 WhatHow Why 125 NIH 1 3000 5000 100 1 2 0.5 1 5 5 1 VC VC 1 20 1,000 1,000 VC 216 437 19 37 34

More information

資料2-3 現行学習指導要領における情報に関する主な記述

資料2-3 現行学習指導要領における情報に関する主な記述 4 9 3 1 22 A B C 3 4 1 3 3 4 342C 3 4 C 1 562B 5 6 B 1 3 1 3 5 2 5 4 5 3 54 3 22 5 3 22 1 4 B1 6 B4 1 2 3 4 5 6 2 A1 2 B2 3 3 22 3 5 6 5 6 2 B 1 5 6 B 5 6 1 1 5 6 2 D 1 D 3 5 3 52 3 1 6CDDVD CDDVD 22 2

More information

Aesculap eurosurery YASARGIL Aneurysm Clip System G. Yasaril Dianne C.H. Yasaril Professor YasarilGuest Book 2 1 1968 CriMo 1812-1/2 2 FD 1970 CriMo 18143-1 1/2 3 FE 1983 PHYOX- ISO 5832-7 1 1/2 4 FT

More information

< F2D C8E8691E63395AA8DFB2E6A7464>

< F2D C8E8691E63395AA8DFB2E6A7464> 1990 CPUE ABC 2-1)ABClimit= 1 Ct 1 =0.6 Cave 1.00 0.8 ABCtarget=ABClimit 0.8 Ct 3 Cave2008 2010 2011 2013ABC ABClimit 170 0.6Cave3-yr1.00 ABCtarget 140 0.80.6Cave3-yr1.00 Cave20082010ABC10 2010 263 2011

More information

M.D.I VDT 29. (1)

M.D.I VDT 29. (1) 5. 5. 5.1 (1 (2 (3 (4 3040 5.2 32 1 1 43 2 44 3 45 13 14 1) 4 45 2 5 46 6 47 7 66 2 8 26 2 1 32 2) 1 2 53 3 39 4 40 5 56 6 29 7 38 8 22 9 22 3 48 2 29 5. 17 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

More information

(MRI) 10. (MRI) (MRI) : (NMR) ( 1 H) MRI ρ H (x,y,z) NMR (Nuclear Magnetic Resonance) spectrometry: NMR NMR s( B ) m m = µ 0 IA = γ J (1) γ: :Planck c

(MRI) 10. (MRI) (MRI) : (NMR) ( 1 H) MRI ρ H (x,y,z) NMR (Nuclear Magnetic Resonance) spectrometry: NMR NMR s( B ) m m = µ 0 IA = γ J (1) γ: :Planck c 10. : (NMR) ( 1 H) MRI ρ H (x,y,z) NMR (Nuclear Magnetic Resonance) spectrometry: NMR NMR s( B ) m m = µ 0 IA = γ J (1) γ: :Planck constant J: Ĵ 2 = J(J +1),Ĵz = J J: (J = 1 2 for 1 H) I m A 173/197 10.1

More information

2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th ed

2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th ed 23344 mfukayama-tky@umin.ac.jp http://pathol.umin.ac.jp/ 19 50 2 / 19 50 3 / http://pathol/umin.ac.jp 1) Basic Pathology (7 th edition): Kumar V, Cotran RS, Robbins SL (eds.), W.B. Saunders, 2002 2) Essential

More information

PSCHG000.PS

PSCHG000.PS FA X SA RS W H O DM AT ACLS TR BCG BCG GDP GDP JO A JC O A ATL W H O GNP OB g ICLS IC L S AED IC L S AED AED Dr. a ODA b c d d d d ddic d c VT VT VT VT VT VT VT VT VT VT VT VT c

More information

マニュアル第4版表紙PDF

マニュアル第4版表紙PDF 5 2004 4 1 5 2004 1968 1993 1994 1996 1998 2001 2004 3 I 1 1 2 2 3 12 4 24 5 48 6 59 7 65 8. 68 9 72 10 76 11 80 12 82 13 84 14 88 15 98 16. 106 17. (AIDS) 108 18 113 19 117 20 119 21 TPN 122 22 125 23.

More information

program.pdf

program.pdf - - FAX E-mailjsnr-office@umin.ac.jp http://jsnr.umin.jp/ Cheryle Tatano Beck Vol. No. ,,, PC Vol. No. USBCD-ROM PC PCOS Windows XPPowerPointMS MSMSP PC Vol. No. , Vol. No. Vol. No. 会場までの交通機関 日本看護研究学会雑誌

More information

日本医師会雑誌第131巻第10号

日本医師会雑誌第131巻第10号 B C 100 12 11 13 3 C 4 C Q&A B C 54 B B B B Q&A B B HBV 20 HBV B B B B HBV HBV HBV HBV 2 HBV HBV HBV A HBV HBV HBV HBV HBV Q37 HBV HBV HBV 1015 B B B Q51 B HBV B B HBV B HBV HBV HBV B B B HBV B HBV HBV

More information

network_now_1602_web掲載用_決定 cap修正.indd

network_now_1602_web掲載用_決定 cap修正.indd 482 28 2016 2 1 1 1 1 The Japan Association of Radiological Technologists ネットワーク ナウ http://www.jart.jp 2016 No.482 2 1 発行所公益社団法人日本診療放射線技師会 105-6131 東京都港区浜松町 2-4-1 世界貿易センタービル 31 階 TEL. 03-5405-3612 FAX.

More information

脳卒中医療体制検討特別委員会 Ⅰ. はじめに recombinant tissue plasminogen activator: rt-pa rt-pa J-MARS rt-pa D D Detection Dispatch Delivery Door Data Decision Drug. Act

脳卒中医療体制検討特別委員会 Ⅰ. はじめに recombinant tissue plasminogen activator: rt-pa rt-pa J-MARS rt-pa D D Detection Dispatch Delivery Door Data Decision Drug. Act 脳卒中医療体制検討特別委員会 Ⅰ. はじめに recombinant tissue plasminogen activator: rt-pa rt-pa J-MARS rt-pa D D Detection Dispatch Delivery Door Data Decision Drug. Act FAST 図 ₁ CPSS World Stroke Organization World Stroke

More information

General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)

General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2) General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2) (3) (4) (Standard Precautions ) (5) ( ) (6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1 2 (1) (2) (3) 4 24 (4) 3 ABC3 (common

More information

244650/05 佐貫利雄

244650/05 佐貫利雄 Part I Part II CIF B kl t kl kl kl B kbk B B B B IEA Energy Prices and Taxes 5A 5A MRI MRI A B A A CCD B 1.5 0.4 UFJFG FG FG HD UFJ Point G etc G UFJ UFJ FG G UFJ m A A A B B C C D D A A A A A A

More information